Harvest Volatility Management LLC Seagen Inc. Transaction History

Harvest Volatility Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$187.64 - $206.25 $172,253 - $189,337	-918 Reduced 13.89%	5,690 $1.1 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $138,052 - $219,732	-1,082 Reduced 14.07%	6,608 $1.34 Million
Q4 2022 Feb 09, 2023	SELL	$117.37 - $139.17 $227,345 - $269,572	-1,937 Reduced 20.12%	7,690 $988,000
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $49,644 - $66,100	-367 Reduced 3.67%	9,627 $1.31 Million
Q2 2022 Aug 03, 2022	SELL	$108.81 - $179.33 $128,613 - $211,968	-1,182 Reduced 10.58%	9,994 $1.77 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $2,990 - $3,946	25 Added 0.22%	11,176 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $394,918 - $528,682	2,770 Added 33.05%	11,151 $1.72 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $452,990 - $540,027	3,180 Added 61.14%	8,381 $1.42 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $171,281 - $204,274	1,268 Added 32.24%	5,201 $821,000
Q1 2021 May 06, 2021	BUY	$137.51 - $190.8 $208,602 - $289,443	1,517 Added 62.79%	3,933 $546,000
Q4 2020 Mar 08, 2021	BUY	$164.63 - $211.93 $397,746 - $512,022	2,416 New	2,416 $423,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Harvest Volatility Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Volatility Management LLC with notifications on news.